Androgen Triggers Gene Fusion which Leads to Prostate Cancer

November 17, 2009

Studies conducted by various independent groups have confirmed the role of gene fusion, involving TMPRSS2 and ETS genes, in leading to prostate cancer. However, the underlying causative factor for this genetic alteration was poorly understood. Now, results of a recent study published in the journal Science have identified androgen as a triggering factor for inducing gene fusion.

Login is required to view articles published in the last 90 days

Why should you subscribe to MediNEWS.Direct!:

- Highly interpretive information as opposed to research information or clinical data
- Hand-picks the best clinical and research studies from 1000s of top journals and publications
- No obtrusive non-medical content or advertisements
- Covers all geographic regions and information from all major conferences

You can now stay abreast of all major medical research and clinical updates with MediNEWS.Direct!.

To subscribe (registration for full text access online) email the editor@medinewsdirect.com with your complete name and professional details.









Please email subscriptions@medinewsdirect.com for support or if you face any trouble while logging in.



Stay ahead of competition with MediNEWS.Direct!
To receive the latest clinical updates and health news alerts, please subscribe to our quarterly magazine in a single step by clicking here



Comments

Comments are closed.